dendritic cells dcvac/pca
Vaccineexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT02107430)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06739226 | Phase 1/Phase 2 (Phase 2) | Dec 10, 2024 | Shenzhen Geno-Immune Medical Institute |
| NCT03514836 | Phase 1/Phase 2 (Phase 2) | May 23, 2018 | Accord Research |
| NCT02137746 | Phase 2 | Dec 1, 2013 | Accord Research |
| NCT02107404 | Phase 2 | Apr 1, 2012 | Accord Research |
| NCT02107430 | Phase 2 | Mar 1, 2012 | Accord Research |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Accord Research | For profit | 4 | 4 | 1 | 2012 |
| Shenzhen Geno-Immune Medical Institute | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1